Advances in Gene Delivery Systems
- PMID: 22200988
- PMCID: PMC3245684
- DOI: 10.2165/11594020-000000000-00000
Advances in Gene Delivery Systems
Abstract
The transfer of genes into cells, both in vitro and in vivo, is critical for studying gene function and conducting gene therapy. Methods that utilize viral and nonviral vectors, as well as physical approaches, have been explored. Viral vector-mediated gene transfer employs replication-deficient viruses such as retro-virus, adenovirus, adeno-associated virus and herpes simplex virus. A major advantage of viral vectors is their high gene delivery efficiency. The nonviral vectors developed so far include cationic liposomes, cationic polymers, synthetic peptides and naturally occurring compounds. These nonviral vectors appear to be highly effective in gene delivery to cultured cells in vitro but are significantly less effective in vivo. Physical methods utilize mechanical pressure, electric shock or hydrodynamic force to transiently permeate the cell membrane to transfer DNA into target cells. They are simpler than viral- and nonviral-based systems and highly effective for localized gene delivery. The past decade has seen significant efforts to establish the most desirable method for safe, effective and target-specific gene delivery, and good progress has been made. The objectives of this review are to (i) explain the rationale for the design of viral, nonviral and physical methods for gene delivery; (ii) provide a summary on recent advances in gene transfer technology; (iii) discuss advantages and disadvantages of each of the most commonly used gene delivery methods; and (iv) provide future perspectives.
Conflict of interest statement
The authors have no conflicts of interest that are directly relevant to the content of this review.
Similar articles
-
Recent advances in nonviral vectors for gene delivery.Acc Chem Res. 2012 Jul 17;45(7):971-9. doi: 10.1021/ar200151m. Epub 2011 Aug 26. Acc Chem Res. 2012. PMID: 21870813 Free PMC article.
-
Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review.Genes (Basel). 2022 Jul 30;13(8):1370. doi: 10.3390/genes13081370. Genes (Basel). 2022. PMID: 36011281 Free PMC article. Review.
-
A review of the tortuous path of nonviral gene delivery and recent progress.Int J Biol Macromol. 2021 Jul 31;183:2055-2073. doi: 10.1016/j.ijbiomac.2021.05.192. Epub 2021 Jun 1. Int J Biol Macromol. 2021. PMID: 34087309 Free PMC article. Review.
-
[Advances in cationic polymers used as nonviral vectors for gene delivery].Sheng Wu Gong Cheng Xue Bao. 2013 May;29(5):568-77. Sheng Wu Gong Cheng Xue Bao. 2013. PMID: 24010355 Review. Chinese.
-
Viral and nonviral delivery systems for gene delivery.Adv Biomed Res. 2012;1:27. doi: 10.4103/2277-9175.98152. Epub 2012 Jul 6. Adv Biomed Res. 2012. PMID: 23210086 Free PMC article.
Cited by
-
Cellular nanomechanics derived from pattern-dependent focal adhesion and cytoskeleton to balance gene transfection of malignant osteosarcoma.J Nanobiotechnology. 2022 Nov 24;20(1):499. doi: 10.1186/s12951-022-01713-1. J Nanobiotechnology. 2022. PMID: 36424661 Free PMC article.
-
CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool.Antibiotics (Basel). 2019 Feb 28;8(1):18. doi: 10.3390/antibiotics8010018. Antibiotics (Basel). 2019. PMID: 30823430 Free PMC article. Review.
-
Evaluation of protective immune response in mice by vaccination the recombinant adenovirus for expressing Schistosoma japonicum inhibitor apoptosis protein.Parasitol Res. 2014 Nov;113(11):4261-9. doi: 10.1007/s00436-014-4104-5. Epub 2014 Sep 4. Parasitol Res. 2014. PMID: 25185668
-
Investigation of the cytokine response to NF-κB decoy oligonucleotide coated polysaccharide based nanoparticles in rheumatoid arthritis in vitro models.Arthritis Res Ther. 2015 Nov 4;17:310. doi: 10.1186/s13075-015-0824-x. Arthritis Res Ther. 2015. PMID: 26531309 Free PMC article.
-
Curative gene therapies for rare diseases.J Community Genet. 2021 Apr;12(2):267-276. doi: 10.1007/s12687-020-00480-6. Epub 2020 Aug 15. J Community Genet. 2021. PMID: 32803721 Free PMC article.
References
-
- Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science. 1995;270:475–80. - PubMed
-
- Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346–58. - PubMed
-
- Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33–40. - PubMed
-
- Barquinero J, Eixarch H, Perez-Melgosa M. Retroviral vectors: new applications for an old tool. Gene Ther. 2004;11 (Suppl 1):S3–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous